Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1994-09-13
1998-11-03
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424435, A61K 3821
Patent
active
058304568
ABSTRACT:
Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The IFN-.alpha. is administered in a solid dosage from, e.g., a saliva-dissolvable lozenge.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3906092 (1975-09-01), Hillerman et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4053582 (1977-10-01), Stickl
patent: 4226848 (1980-10-01), Nagai et al.
patent: 4250163 (1981-02-01), Nagai et al.
patent: 4273703 (1981-06-01), Osther et al.
patent: 4276282 (1981-06-01), Sugimoto et al.
patent: 4460574 (1984-07-01), Yabrov
patent: 4462985 (1984-07-01), Cummins, Jr.
patent: 4465702 (1984-08-01), Eastman et al.
patent: 4496537 (1985-01-01), Kwan
patent: 4497795 (1985-02-01), Cummins
patent: 4507281 (1985-03-01), Asculai et al.
patent: 4572832 (1986-02-01), Kigasawa et al.
patent: 4605555 (1986-08-01), Sato et al.
patent: 4649075 (1987-03-01), Jost
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4699136 (1987-10-01), Krauser
patent: 4710191 (1987-12-01), Kwiatek et al.
patent: 4713239 (1987-12-01), Babaian et al.
patent: 4746508 (1988-05-01), Carey et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4803072 (1989-02-01), Dalton et al.
patent: 4820515 (1989-04-01), Cummins
patent: 4828830 (1989-05-01), Wong
patent: 5215741 (1993-06-01), Young et al.
Goodman & Gilman The Pharmacological Basis of Therapeutics 7th Edition, (MacMillan Pub Co., 1985) pp. 6, 30, 31.
5 Agricultural Genetics Report (1986), Interferon Approved for Horse Use.
Amarillo Daily News, Section C, Oct. 25, 1985. "New product aims to combat effects of shipping fever".
Antosh, Nelson, Houston Chronicle, 30th Dec., 1984. Stafford firm will be first to market interferon-based product for cattle.
Aguet, Nature, 1980 284 459-461. High Affinity Binding of .sup.125 I-Labelled Mouse Interferon to a Specific Cell Surface Receptor.
Arnaoudova, et al., Arch. Immunologiae et Therapiae Experimentalis 731-736 (1977) Treatment and Prevention of Acute Viral, Respiratory Infections in Children with Leukocytic Interferon, 25.
Bechtol, et al., "Interferon Potential", Feedlot Health, The Drovers Journal Magazine, Sep. 1985.
Nature vol. 286 p. 110 (10 Jul. 1980), Interferon Nomenclature.
Beef, Dec., 1984, New Interferon Product Approved in Texas to Control Shipping Fever.
Biotechnology News, 15th Aug., 1984.
Biotechnology, Oct. 1984, p. 841.
Borecky, Acta viral. 30: 161-169, 1986. Current View on the Perspectives of Interferon Therapy.
Cantell, K., Interferon 1979 vol. 1 (Ed. I. Gresser) Academic Press 1979 "Why is Interferon Not in Clinical Use Today?".
Cornett, The Drovers Journal Magazine, Oct. 1986. Interferon Tests Show Potential.
Cummins, et al., Abstract of "High Dose Oral, But Not Intraruminal, Human Interferon Alpha May Depress Feed Intake of Cattle," Abstract #11-17.
De Maeyer, Interferons and the Immune System, in Interferon, vol. 1: General and Applied Aspects--A. Billiau (ed.) pp. 167-185 (1984).
Ermolieva, H.M. et al., Journal Antibiotiki N12, pp. 1034-1039 (1967), Experimental Clinical Studies of Endogenous and Exogenous Interferons.
Dai Jia-Ziong, et al., Foreign Pediatrics Medical Annual 1983, 2--72-77 The Efficacy of Interferon in Common Pediatric Viral Infections.
Dai Jia-Ziong, et al., Chinese Pediatrics Journal, 1983, 21, 357-358., Preliminary Observations of aerosol Interferon in the Treatment of Viral Infections in Respiratory Tract.
Dainyak, L.B. et al., Vestnik Otolaryngology, pp. 59-61, N2 (Moscow 1977). Interferon Treatment of Chronic Tonsillitis.
Drobotko, L.N. et al., Stomatologia pp. 53-55, N1 1974. Treatment with Interferon Ointment of Acute Herpetic Stomatitis in Children.
Farr, B.M., et al., Antimicrobial Agents and Chemotherapy, 1984, 26 31-34, Intranasal Interferon-a2 for Prevention of Natural Rhinovirus Colds.
Feedlot Management, Aug. 1985, The Interferon Difference.
Flury, et al., Clinical Experiences with Interferon Therapy 1401-1405.
Fort Bend Business Journal, Jan./Feb. 1985, Stafford Firm Markets New Interferon-Based Drug.
Globe News, Amarillo, Texas (1984).
Goodman & Gilman, "The Pharmacological Basis of Therapeutics" 7th Edition; MadMillan Publishing Company, New York, 1985 pp. 5-9.
Greenberg, S.B. et al. Texas Rep. Biol. Med. 41:549-554 (1981) "Trials of Interferon in Respiratory Infections in Man".
Gresser, et al., Nature, 1974 251 543-545. "Pronounced Antiviral Activity of Human Interferon or Bovine and Procine Cells".
Igoshin, et al., Journal Vestnik Dermatoloty, Venrology (Moscow), vol. 10, Oct., pp. 41-43, 1983. Remote Results of Combined Therapy of Patients With a Psoriasis Using Interferon Inhalation.
Imanishi, et al.,Journal of Interferon Research, vol. I, Nov. 1980, 169-178, "The Preventive Effect of Human Interferon-Alpha Preparation on Upper Respiratory Disease.
Billiau, Alfons, Interferon vol. 1 (Ed.) General and Applied Aspects (Ed. A Billiau) Amsterdam: Elsevier, 23, 1984. "The Main Concepts & Achievements in Interferon Research: A Historical Account."
Jacobs, et al., Science 214: 1026-1028 (1981) "Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis".
Kajander, The Lancet (1979) 1, 984-985.
Levin, Isr. J. Med. Sci. 19 955-958 (1983) "Clinical Use of Interferon in Viral Infections".
Lotze, Michael, Treatment of immunologic disorders in AIDS, AIDS (DeVita et al., eds. 1985), pp. 235-263.
McGraw-Hill Concise Encyclopedia of Science & Technology, 1984.
The Merck Index, Merck & Co., Inc. 1983, 724-725.
Modern Horse Breeding, Jul. 1986, Alpha Interferon Shows Promise in Fighting Equine Respiratory Disease.
Paramonova, Treatment of Tonsillitis of Viral Etiology by Interferon, Actual Problems of Otolaryngology (Proceedings), Tashkent 1978.
Paramonova, et al., Materials from Conference on the Study of Biosynthesis, Antimetabolites, and Chemotherapy of Viral Infections, Dec. 19-20, 1968, N8 (18).
Phillpotts, et al., Journal of Interferon Research 1984., 535-541 Intranasal Lymphoblastoid Interferon ("Wellfron") Prophylaxis Against Rhinovirus and Influenza Virus in Volunteer.
Research News Report, The Texas Agricultural Experiment Station, The Texas A&M University System (Oct. 31, 1984).
Sanders, "Dorland's Illustrated Medical Dictionary" (1974), pp. 232, 1019, 1094, 1098, 1175-77.
Scott, D.M. & D.A.J. Tyrrell, Br. Med. J. 1568-1682 (1980) "Interferon: Therapeutic Fact or Fiction for the '80s".
Sisoeva, O.B., Transactions of the All Union Research Institute of Influenza (1972 Change of the Markers of Immune Status of Children Under the Influence of Interferon and Extract of Eleuterokokk, Prophylaxis of Influenza and Other Acute Respiratory Diseases in Children).
Soloviev, et al., Plenum Press NY 1073 pp. 128-135, Interferon Theory and Application.
Streuli et al., Proc. Natl. Acad. Sci., 1981 78 2848-2852. Target Cell Specificity of Two Species of Human Interferon-Alpha Produced in Escherichia coli and of Hybrid Molecules Derived From Them.
Strustsovkaya, Journal Antibiotiki, vol. 20 #2, pp. 170-172, 1975. Experience with Use of Leukocytic Interferon and Metacyl in Children Suffering from Influenza.
Sun, Chong-Son et al., Journal of Interferon Research 1984, 449-459 Efficacy of Aerosolized Recombinant Interferons Against Vesicular Stomatitis Virus-Induced Lung Infection in Cotton Rats.
Tovey, et al., J. Gen. Virol., 1977 36 341-344. "Antiviral Activity of Bovine Interferons on Primate Cells".
Ulanovskaya, T.I. et al., Proceedings of Scientific-Practical Conference, Moscow (1971) Use of Leukocyte Interferon for Treatment and Prophylaxis of Acute Respiratory Diseases in Children of the First Months of Life.
Vander, et al., Human Physiology The Mechanisms of Body Function 1980, McGraw Hill 3rd Edition, 421-422.
Williams & Warwick, Gray's Anatomy, (36th Edition 1980). pp. 1267-1231.
Yamamoto, et al., Journal of Interferon Research 1986, 143-152. Human Alpha- and Beta-Interferon But Not Gamma-Suppress the In Vitro Replication of LAV, HTLV-III and ARV-2.
Yonehara et al., J. Biol. Chem., 1983 258 (15) 9
Fitzgerald David L.
The Texas A&M University System
LandOfFree
Treatment of viral disease with oral interferon-.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of viral disease with oral interferon-.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of viral disease with oral interferon-.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686640